Displaying 11 - 20 of 245 results
Studying Hemangiosarcoma Subtypes and Treatment Response
Researchers are studying if hemangiosarcoma subtypes influence how affected dogs respond to treatment – a step toward precision medicine for these patients.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Investigating a Genetic Mutation in Canine Hemangiosarcoma
Researchers will investigate the role of a genetic mutation found in about one third of dogs diagnosed with hemangiosarcoma, in an effort to find new therapies for dogs affected by this aggressive and highly metastatic cancer.
Developing A Test for Early Detection of Splenic Hemangiosarcoma
Researchers will study changes in microRNAs in the blood of dogs enrolled in the Golden Retriever Lifetime Study and diagnosed with hemangiosarcoma to identify early disease biomarkers.
Working Toward More Effective Treatments for Hemangiosarcoma
Researchers are exploring if a protein found in some human cancers is also present in hemangiosarcoma tumors, and is a feasible therapy target.
Working Toward an Early Diagnostic Test for Hemangiosarcoma
Researchers will study the feasibility of using molecules called microRNAs as an early detection tool for hemangiosarcoma, an often-fatal cancer in dogs.
Finding Ways to Block Hemangiosarcoma Tumor Growth
Researchers will investigate how hemangiosarcoma cells use cholesterol and lipids to promote tumor growth and look at ways to block tumor cells from using these metabolic fuels.
Curbing Tumor Growth and Chemotherapy Resistance in Canine Hemangiosarcoma
Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.
Finding Novel Therapy Targets for Hemangiosarcoma to Advance Treatment
Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.